About Us
Venture Investment
Staff Services
Student Enterprise
Edinburgh Innovations
Open menu
Home
Expertise
Collaboration
Technology
Case Studies
News
Events
Contact Us
Close menu
Home
Expertise
Collaboration
Technology
Case Studies
News
Events
Contact Us
About Us
Venture Investment
Staff Services
Student Enterprise
Search
Invizius - H-Guard against inflammation
Despite improvements in dialysis therapy, cardiovascular disease remains the leading cause of death for almost half of all dialysis patients and life expectancy on dialysis is just one-third of that for the general population.
Score: 12
Invizius awarded major funding to bring dialysis treatment to clinic
Score: 6
Invizius wins second Biomedical Catalyst Grant to take H-Guard into new field
Score: 6